drugset / Trial / NCT01616069

Assessment of Hemodynamic Response in Cardiopulmonary Bypass Graft After Cardiopulmonary Bypass Using Transesophegeal Echocardiography

NCT01616069

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a double blind randomization study, assessing hemodynamic response in patients who underwent a cardiopulmonary bypass graft (CABG) with cardiopulmonary bypass (CPB) using intraoperative trasnesophageal echocardiography (TEE) to know what inotropic drug will be batter to improve the heart function. Epinephrine, milrinone, dobutamine and levosimendan will be assessment.

Timeline

Start
2012-02
Primary completion
2012-02
Completion
2013-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Epinephrine Other / unclassified 0.06 ug/kg
Comparator Levosimendan Other / unclassified 0.2 ug/kg

Indications

No indication recorded.